Sequence
sequencehq.comX / TwitterLinkedIn

Automates quoting, billing, and revenue recognition for B2B SaaS companies with usage-based pricing

Founders
Eamon JubbawyEnda CahillRiya Grover
645 Deal Lead
William Hess
Industry
Fintech
Entry Stage
Series A
Status
Acquired
Investment Date
2025
Company Overview

Sequence automates the full quote-to-cash workflow—including CPQ, billing, invoicing, collections, and revenue recognition—for B2B SaaS and fintech companies with complex, usage-based pricing models. The platform serves as a modern replacement for legacy subscription billing systems that cannot support flexible deal structures.

Investment Rationale

The team is composed of elite founders with multiple exits (Feedr, Onfido) and deep experience in SaaS/finance from companies like Square, Choco, GoCardless, and Tessian. Sequence is an AI-native revenue platform that utilizes a flexible pricing data model and AI-driven contract ingestion. This makes it "10x faster and more flexible than legacy incumbents" built for the subscription era. The system can be deployed in days, which is a significant advantage over the 6–9 months typically required with legacy systems.

Exit Summary

Intuit acquired Sequence, the AI-native revenue management platform that automates the quote-to-revenue process for B2B companies with complex, usage-based pricing. The acquisition was strategic because Sequence's deal configuration, pricing, billing, invoicing, collections and revenue recognition fill a key gap for growing businesses on Intuit, giving them a modern alternative to legacy billing systems. Post-acquisition, Intuit is pairing Sequence with Intuit Enterprise Suite and QuickBooks Online Advanced to give mid-market companies an end-to-end revenue workflow inside its platform.

In the News

The latest articles on Sequence’s product releases, fundraising, and awards.

Introducing Sequence 2.0: AI-Native Revenue Automation
Product Launch·Sequence
Oct 2025
Sequence Secures $20M Series A to Scale Revenue Automation
Raised·Sequence
Oct 2025